(Q38215608)

31 August 2017

Metal complexes and metalloproteases: targeting conformational diseases (English)

1 reference

31 August 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24870829%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

Sylvestre Bonnet

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24870829%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

publication date

1 August 2014

1 reference

31 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24870829%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24870829%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24870829%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

1346-1357

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24870829%20AND%20SRC:MED&resulttype=core&format=json

The LZT proteins; the LIV-1 subfamily of zinc transporters

5 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Active-site zinc ligands and activated H2O of zinc enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

JWA suppresses tumor angiogenesis via Sp1-activated matrix metalloproteinase-2 and its prognostic significance in human gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Matrix metalloproteinase-2 governs lymphatic vessel formation as an interstitial collagenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

MMP-8 overexpression and persistence of neutrophils relate to stress-impaired healing and poor collagen architecture in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Truncated active human matrix metalloproteinase-8 delivered by a chimeric adenovirus-hepatitis B virus vector ameliorates rat liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Matrix metalloproteinases: a review of their structure and role in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Matrix metalloproteinases: changing roles in tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

The missing link in the amyloid cascade of Alzheimer's disease - metal ions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Folding dynamics of phenylalanine hydroxylase depends on the enzyme's metallation state: the native metal, iron, protects against aggregate intermediates

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Biophysical studies of the amyloid β-peptide: interactions with metal ions and small molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Acidic pH retards the fibrillization of human Islet Amyloid Polypeptide due to electrostatic repulsion of histidines

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

The workings of the amyloid diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Plasmonics for the study of metal ion-protein interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

The structural basis of protein folding and its links with human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

How the binding and degrading capabilities of insulin degrading enzyme are affected by ubiquitin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Metal ions affect insulin-degrading enzyme activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Metallostasis and amyloid β-degrading enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Copper(I) and copper(II) inhibit Aβ peptides proteolysis by insulin-degrading enzyme differently: implications for metallostasis alteration in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Enzyme solid-state support assays: a surface plasmon resonance and mass spectrometry coupled study of immobilized insulin degrading enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

The proteolytic activity of insulin-degrading enzyme: a mass spectrometry study

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Challenges for metals in medicine: how nanotechnology may help to shape the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Aluminum modulation of proteolytic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Synthetic active site-directed inhibitors of metzincins: achievement and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Hydroxamates: relationships between structure and plasma stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Identifying chelators for metalloprotein inhibitors using a fragment-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Investigating chelating sulfonamides and their use in metalloproteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

New hydroxypyrimidinone-containing sulfonamides as carbonic anhydrase inhibitors also acting as MMP inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Novel 1-hydroxypiperazine-2,6-diones as new leads in the inhibition of metalloproteinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Matrix metalloproteinases: multifunctional contributors to tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Matrix metalloproteinase inhibitors (MMPIs): the beginning of phase I or the termination of phase III clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Discovery of a New Class of Potent MMP Inhibitors by Structure-Based Optimization of the Arylsulfonamide Scaffold

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Recent developments in the design of specific Matrix Metalloproteinase inhibitors aided by structural and computational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Platinum complexes can inhibit matrix metalloproteinase activity: platinum-diethyl[(methylsulfinyl)methyl]phosphonate complexes as inhibitors of matrix metalloproteinases 2, 3, 9, and 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Structure of matrix metalloproteinase-3 with a platinum-based inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Kinetics and thermodynamics of irreversible inhibition of matrix metalloproteinase 2 by a Co(III) Schiff base complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Matrix metalloproteinases as valid clinical targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Structure based drug design of angiotensin-I converting enzyme inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Inhibition of zinc metallopeptidases in cardiovascular disease--from unity to trinity, or duality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

New drugs, procedures, and devices for hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Zinc-binding groups modulate selective inhibition of MMPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Mixed inhibitors of angiotensin-converting enzyme (EC 3.4.15.1) and enkephalinase (EC 3.4.24.11): rational design, properties, and potential cardiovascular applications of glycopril and alatriopril

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Inhibition of neprilysin by infusion of thiorphan into the hippocampus causes an accumulation of amyloid Beta and impairment of learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Disruption of zinc homeostasis and the pathogenesis of senile dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Therapeutic redistribution of metal ions to treat Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

The Alzheimer's therapeutic PBT2 promotes amyloid-β degradation and GSK3 phosphorylation via a metal chaperone activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Differential modulation of Alzheimer's disease amyloid beta-peptide accumulation by diverse classes of metal ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Copper complexes as therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Metallodrugs in medicinal inorganic chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Functions of epidermal growth factor receptor in cisplatin response of thyroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Zn(II)-Chlorido complexes of phytohormone kinetin and its derivatives modulate expression of inflammatory mediators in THP-1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Metal complexes as artificial proteases: toward catalytic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Target-selective peptide-cleaving catalysts as a new paradigm in drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Which one among aspartyl protease, metallopeptidase, and artificial metallopeptidase is the most efficient catalyst in peptide hydrolysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Synthetic artificial peptidases and nucleases using macromolecular catalytic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Target-directed catalytic metallodrugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Artificial metalloprotease with active site comprising aldehyde group and Cu(II)cyclen complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Cleavage agents for soluble oligomers of amyloid beta peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Soluble artificial metalloproteases with broad substrate selectivity, high reactivity, and high thermal and chemical stabilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Design and synthesis of artificial phospholipid for selective cleavage of integral membrane protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Interaction of molybdocene dichloride with cysteine-containing peptides: coordination, regioselective hydrolysis, and intramolecular aminolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Calpain inhibition attenuates angiotensin II-induced abdominal aortic aneurysms and atherosclerosis in low-density lipoprotein receptor-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Doxycycline exhibits anti-inflammatory activity in CF bronchial epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Pivotal role of matrix metalloproteinase 13 in extracellular matrix turnover in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Role of matrix metalloproteinase-9 (MMP-9) in striatal blood-brain barrier disruption in a 3-nitropropionic acid model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

MMP-2 regulates Erk1/2 phosphorylation and aortic dilatation in Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

ADAMTSL6β protein rescues fibrillin-1 microfibril disorder in a Marfan syndrome mouse model through the promotion of fibrillin-1 assembly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Identification of a mutation causing deficient BMP1/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Phase I study of eptifibatide in patients with sickle cell anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Topically applied vitamin C enhances the mRNA level of collagens I and III, their processing enzymes and tissue inhibitor of matrix metalloproteinase 1 in the human dermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Matrix metalloproteinases and their multiple roles in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Evaluation of peripheral matrix metalloproteinase-1 in Parkinson's disease: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Cellular prion protein regulates its own α-cleavage through ADAM8 in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Clearance of extracellular misfolded proteins in systemic amyloidosis: experience with transthyretin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Loss of the metalloprotease ADAM9 leads to cone-rod dystrophy in humans and retinal degeneration in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Insulin-degrading enzyme (IDE): a novel heat shock-like protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Metalloproteinases in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Maturation of frataxin within mammalian and yeast mitochondria: one-step processing by matrix processing peptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Elevated levels of matrix metalloproteinases-9 and -1 and of tissue inhibitors of MMPs, TIMP-1 and TIMP-2 in postmortem brain tissue of progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

The role of copper(II) and zinc(II) in the degradation of human and murine IAPP by insulin-degrading enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Structural studies of a bifunctional inhibitor of neprilysin and DPP-IV

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Serum levels and polymorphisms of matrix metalloproteinases (MMPs) in carotid artery atherosclerosis: higher MMP-9 levels are associated with plaque vulnerability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Carotid atherosclerotic plaque matrix metalloproteinase-12-positive macrophage subpopulation predicts adverse outcome after endarterectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Role of matrix metalloproteinase-9 in a mouse model for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

Tissue inhibitor of metalloproteinases-3 (TIMP-3) expression is increased during serum deprivation-induced neuronal apoptosis in vitro and in the G93A mouse model of amyotrophic lateral sclerosis: a potential modulator of Fas-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MT00076E

https://api.fatcat.wiki/v0/release/pfd73gh5lnf57mwfexzxoyg7om

21 January 2018

Identifiers

1 reference

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_pfd73gh5lnf57mwfexzxoyg7om

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pfd73gh5lnf57mwfexzxoyg7om

mapped directly with Wikidata item

30 July 2022

based on heuristic

1 reference

https://api.fatcat.wiki/v0/release/pfd73gh5lnf57mwfexzxoyg7om